The Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care combines extensive research with clinical expertise, so we can build upon current programs and develop new knowledge in treating pancreas cancer. Our physician-scientists are internationally recognized for their contributions to understanding what causes pancreas cancer, how it develops, and how to treat the cancer in its early stages.
Goals of Clinical Research at The Skip Viragh Center include:
The Skip Viragh Outpatient Cancer Building.
Develop new scientific initiatives with direct outcomes
Develop and test new platforms for delivery of vaccines for patients with all stages of pancreatic cancer
Understand how cancers trick the immune system into protecting the disease and how we can develop new therapies that dismantle this protection
Identify new proteins on pancreas cancer cells that can be selectively targeted with new therapies
Improve pain management
Optimize sequencing of surgery and chemo radiation
Identify the best conditions for using radiation therapy as well as combining it with other therapies
Develop biomarkers for early detection
Identify stem-like cells that may give rise to pancreas cancer cells
Screen high risk patients to identify pancreas cancer earlier when the cancer may be curable
Maintain and analyze a familial pancreas cancer database, the largest-known of its type
Analyze the pancreas cancer genome, sequenced by Johns Hopkins scientists
Develop methods to predict response to chemotherapy
Surgical volumes are the number of times a hospital has done a specific surgical procedure in a defined time period. Hospitals that do more of a specific surgical procedure tend to have better outcomes for their patients than hospitals that do less of them. To view the average number of times that pancreas surgery is performed each year at The Johns Hopkins Health System Hospitals, please click here.